Karev Georgy P, Novozhilov Artem S, Koonin Eugene V
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Biol Direct. 2006 Oct 3;1:30. doi: 10.1186/1745-6150-1-30.
One of the mechanisms that ensure cancer robustness is tumor heterogeneity, and its effects on tumor cells dynamics have to be taken into account when studying cancer progression. There is no unifying theoretical framework in mathematical modeling of carcinogenesis that would account for parametric heterogeneity.
Here we formulate a modeling approach that naturally takes stock of inherent cancer cell heterogeneity and illustrate it with a model of interaction between a tumor and an oncolytic virus. We show that several phenomena that are absent in homogeneous models, such as cancer recurrence, tumor dormancy, and others, appear in heterogeneous setting. We also demonstrate that, within the applied modeling framework, to overcome the adverse effect of tumor cell heterogeneity on the outcome of cancer treatment, a heterogeneous population of an oncolytic virus must be used. Heterogeneity in parameters of the model, such as tumor cell susceptibility to virus infection and the ability of an oncolytic virus to infect tumor cells, can lead to complex, irregular evolution of the tumor. Thus, quasi-chaotic behavior of the tumor-virus system can be caused not only by random perturbations but also by the heterogeneity of the tumor and the virus.
The modeling approach described here reveals the importance of tumor cell and virus heterogeneity for the outcome of cancer therapy. It should be straightforward to apply these techniques to mathematical modeling of other types of anticancer therapy.
Leonid Hanin (nominated by Arcady Mushegian), Natalia Komarova (nominated by Orly Alter), and David Krakauer.
确保癌症稳健性的机制之一是肿瘤异质性,在研究癌症进展时必须考虑其对肿瘤细胞动力学的影响。在癌症发生的数学建模中,没有一个统一的理论框架能够解释参数异质性。
在此,我们制定了一种建模方法,该方法自然地考虑了内在的癌细胞异质性,并通过肿瘤与溶瘤病毒之间相互作用的模型进行说明。我们表明,在同质模型中不存在的几种现象,如癌症复发、肿瘤休眠等,在异质环境中会出现。我们还证明,在应用的建模框架内,为了克服肿瘤细胞异质性对癌症治疗结果的不利影响,必须使用异质群体的溶瘤病毒。模型参数的异质性,如肿瘤细胞对病毒感染的易感性以及溶瘤病毒感染肿瘤细胞的能力,可导致肿瘤复杂、不规则的演变。因此,肿瘤-病毒系统的准混沌行为不仅可由随机扰动引起,也可由肿瘤和病毒的异质性引起。
本文所述的建模方法揭示了肿瘤细胞和病毒异质性对癌症治疗结果的重要性。将这些技术应用于其他类型抗癌治疗的数学建模应该很简单。
列昂尼德·哈宁(由阿尔卡季·穆舍吉安提名)、娜塔莉亚·科马罗娃(由奥利·阿尔特提名)和大卫·克拉考尔。